Miura Partners has become the new majority stakeholder of functional ingredients company, HealthTech BioActives (HTBA).
The company, which is known for its citrus flavonoids and vitamin B12 ingredients, will now have Miura's support in its ongoing growth strategy.
Together, the organisations will focus on expanding HTBA's global reach in providing functional health, pharmaceutical active ingredient, taste modulation and animal nutrition solutions to both the nutraceutical and pharmaceutical industries.
Under HTBA's previous owner, the company pursued an international expansion initiative, which also aimed to modernise its manufacturing protocol.
With locations in two locations within Spain and a subsidiary in Cincinnati, Ohio, the company aims to provide nutritional solutions to customers across the globe.
CEO of HTBA, Alexandre Valls-Coma, “The agreement of our new shareholder structure with Miura Partners is an important milestone for HTBA, reinforcing our position as a rising star in the health and nutrition industry,”
“We remain fully focused on our mission of unlocking the power of nature through our proprietary processes and high-purity ingredients, with a genuine commitment to sustainability. Staying true to these principles has enabled us to enhance the health and well-being of both people and animals for over 40 years, and made us a global leader in the manufacturing and distribution of flavonoids and active forms of vitamin B12. Now, as we begin our partnership with Miura, we can’t wait to take our ambitious growth plans to the next level.”